$97.37 Million in Sales Expected for Axcelis Technologies Inc (ACLS) This Quarter
Wall Street brokerages predict that Axcelis Technologies Inc (NASDAQ:ACLS) will announce sales of $97.37 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Axcelis Technologies’ earnings, with estimates ranging from $97.10 million to $97.50 million. Axcelis Technologies reported sales of $104.48 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 6.8%. The business is expected to report its next quarterly earnings results on Thursday, November 1st.
According to Zacks, analysts expect that Axcelis Technologies will report full year sales of $450.00 million for the current fiscal year. For the next fiscal year, analysts expect that the company will post sales of $498.87 million, with estimates ranging from $490.00 million to $511.60 million. Zacks’ sales averages are an average based on a survey of research firms that cover Axcelis Technologies.
Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, August 2nd. The semiconductor company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.08. The company had revenue of $119.30 million during the quarter, compared to analysts’ expectations of $116.33 million. Axcelis Technologies had a net margin of 28.57% and a return on equity of 16.84%. The firm’s revenue for the quarter was up 16.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 EPS.
Several hedge funds have recently modified their holdings of ACLS. Mount Yale Investment Advisors LLC bought a new position in shares of Axcelis Technologies during the first quarter worth about $143,000. Piedmont Investment Advisors LLC bought a new position in shares of Axcelis Technologies during the second quarter worth about $148,000. Bank of Montreal Can bought a new position in shares of Axcelis Technologies during the second quarter worth about $161,000. Metropolitan Life Insurance Co. NY lifted its position in shares of Axcelis Technologies by 362.2% during the second quarter. Metropolitan Life Insurance Co. NY now owns 10,363 shares of the semiconductor company’s stock worth $205,000 after purchasing an additional 8,121 shares during the last quarter. Finally, LSV Asset Management bought a new position in shares of Axcelis Technologies during the second quarter worth about $209,000. 84.59% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ:ACLS traded down $0.30 on Friday, reaching $19.85. The stock had a trading volume of 3,511 shares, compared to its average volume of 290,343. The stock has a market cap of $655.20 million, a P/E ratio of 13.55 and a beta of 0.85. Axcelis Technologies has a 12-month low of $18.35 and a 12-month high of $37.05.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.
Featured Article: How much money do you need to begin day trading?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.